Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CAN CSA C22.2 No. 60601-2-47-14 (2018): Requirements for Ambulatory Electrocardiographic Systems
A Comprehensive Guide to the Canadian Adoption of IEC 60601-2-47 for Holter Monitor Safety and Performance
Introduction
The standard CAN CSA C22.2 No. 60601-2-47-14 (2018) is the Canadian national adoption of the international standard IEC 60601-2-47:2012, with modifications to reflect national regulatory requirements and the CSA C22.2 series for electrical equipment. It specifies particular requirements for the basic safety and essential performance of ambulatory electrocardiographic systems, commonly known as Holter monitors. These systems are designed to continuously record and analyze ECG signals over extended periods, typically 24 to 48 hours, for the diagnosis of arrhythmias, ischemic events, and other cardiac conditions. Compliance with this standard is essential for obtaining CSA certification and meeting Canadian medical device regulatory requirements under the Medical Devices Regulations (SOR/98-282).
Scope of the Standard
The standard applies to ambulatory ECG systems that are intended for use in professional healthcare facilities, outpatient diagnostic settings, and in some cases for home use under medical prescription. It covers complete systems including the recording device, analysis software, and playback equipment if provided.
The following are explicitly within the scope:
- Continuous ambulatory ECG recorders (single-channel and multi-channel)
- Holter analysis systems for arrhythmia detection and ST-segment analysis
- Patient-applied leads and cables considered part of the system
- Interfaces for external data transmission and report generation
The standard does not cover:
- Conventional electrocardiographs covered by IEC 60601-2-25
- Real-time telemetry monitoring systems
- Implantable cardiac monitors or pacemakers
- Standalone data management systems not marketed as part of Holter systems
Key Technical Requirements
The standard integrates the general safety requirements of IEC 60601-1:2005+AMD1:2012 (Medical electrical equipment — General requirements for basic safety and essential performance) and adds particular requirements unique to ambulatory ECG systems. The main areas are grouped into safety, performance, and environmental/EMC.
Safety and Electrical Requirements
Patient safety is paramount. The standard mandates:
- Protection against electric shock: Very low patient leakage currents (typically ≤ 10 µA under normal conditions) and reinforced insulation between patient connections and mains parts.
- Defibrillation protection: The system must withstand the application of a defibrillator discharge without damage and without exceeding specified leakage currents.
- Mechanical robustness: Enclosures and connectors must resist normal handling and drop conditions.
- Biocompatibility: Electrodes and patient-contacting materials must meet ISO 10993 requirements.
Performance and Signal Fidelity
Essential performance criteria ensure that recorded ECG signals are suitable for diagnostic interpretation. Key parameters are summarized in the table below.
| Parameter | Requirement | Test Conditions |
|---|---|---|
| Frequency response | 0.05 Hz – 60 Hz (±10%) | Full amplitude range, 25 mm/s playback |
| Input dynamic range | ±5 mV (minimum) | With AC differential input |
| Noise (peak-to-peak) | ≤ 30 µV | Short-circuit input at recording speed |
| Input impedance | ≥ 5 MΩ at 10 Hz | Between any two electrodes |
| Heart rate accuracy | ±2% or ±1 bpm, whichever is larger | Over range 30–250 bpm |
| Arrhythmia detection (sensitivity) | ≥ 90% for ventricular events | Validated arrhythmia database |
| ST-segment accuracy | ±0.04 mV at J+60 ms | Clinically validated signals |
Environmental and EMC Requirements
Ambulatory recorders must operate under conditions typical of patient use. The standard requires:
- Temperature and humidity: Operation from 10 °C to 40 °C, 15% to 95% relative humidity (non-condensing).
- Electromagnetic compatibility (EMC): Compliance with IEC 60601-1-2 (Edition 4 or Canadian adoption), including immunity to radiated and conducted disturbances from common sources such as mobile phones and hospital equipment.
- Battery life: The system must maintain specified performance for the intended recording duration (typically 24–48 hours) without recharging.
Implementation Tip: When designing the analog front end, pay special attention to input protection circuits and common-mode rejection. A test using the IEC 60601-2-47 calibration pulse (1 mV, 100 ms) is a quick way to verify basic recording fidelity before full validation.
Warning: Defibrillation protection must be verified using the test circuit specified in IEC 60601-1:2005+AMD1:2012, Clause 8.5.5.1. Failure to withstand a 5 kV defibrillation pulse can result in compromise of patient insulation and risk of shock.
Implementation Highlights for Manufacturers
Integrating the requirements of this standard into a development project involves careful planning and validation. Key areas to address include:
- Risk management: Follow ISO 14971 to identify hazards (e.g., loss of ECG signal, misinterpretation of arrhythmias) and implement controls.
- Algorithm validation: Arrhythmia analysis algorithms must be validated against annotated databases (e.g., MIT-BIH, AHA) to prove sensitivity and specificity. The standard requires a clinical validation report.
- Usability engineering: The system should be designed to prevent common user errors, such as incorrect lead placement or data export mistakes. Refer to IEC 62366-1.
- Labeling and instructions: The accompanying documents must include warnings about defibrillation, appropriate use, and limitations of analysis results.
Good Practice: Early engagement with a recognized certification body (e.g., CSA Group or Intertek) can help identify gaps in test plans and reduce time to market. Many bodies offer a “design review” service that evaluates conformity before final testing.
Critical Compliance Note: In Canada, ambulatory ECG systems are considered Class II medical devices under Health Canada’s Medical Devices Regulations. In addition to meeting CAN CSA C22.2 No. 60601-2-47-14, manufacturers must establish a Quality Management System compliant with ISO 13485 and submit a medical device licence application (or amendment) to Health Canada before selling the device.
Compliance and Certification Notes
The standard is part of the CSA C22.2 series of safety standards for electrical equipment. Manufacturers seeking compliance should follow these steps:
- Determine the applicable edition: The 2018 edition is the current version. Always verify with the certification body for any amendments.
- Prepare test samples: Provide a fully functional recording system (recorder, analysis software, and cables). Software must be declared as configurable and validated.
- Conduct testing: Testing typically covers safety (IEC 60601-1), performance (ISO 60601-2-47), and EMC (IEC 60601-1-2). The CB Scheme can be used to reduce duplication.
- Obtain certification: Successful testing yields a CSA certificate, which may be accepted by other Canadian provinces and territories.
- Maintain compliance: The manufacturer must report significant changes to the design, manufacturing, or labeling, and may be subject to periodic factory inspections.
The standard also includes several Canadian deviations from the IEC base. For example, it specifies Canadian voltages (120 V/60 Hz) and incorporates requirements from the Canadian Electrical Code for external power supplies. These deviations are clearly flagged in the normative text.
Frequently Asked Questions
Q: How does CAN CSA C22.2 No. 60601-2-47-14 differ from IEC 60601-2-47:2012?
A: The Canadian standard adopts the IEC technical requirements but includes national deviations to address Canadian electrical supply conditions, official language requirements (English and French labeling), and specific references to Canadian regulations (e.g., Medical Devices Regulations). Manufacturers using the international standard should review the Canadian deviations carefully.
A: The Canadian standard adopts the IEC technical requirements but includes national deviations to address Canadian electrical supply conditions, official language requirements (English and French labeling), and specific references to Canadian regulations (e.g., Medical Devices Regulations). Manufacturers using the international standard should review the Canadian deviations carefully.
Q: Can an IEC 60601-2-47 certified device be sold in Canada without additional testing?
A: Yes, if the manufacturer obtains a CB Test Certificate (IECEE) covering the IEC 60601-2-47 requirements and then applies for national certification through a NCB (e.g., CSA Group). However, Canadian deviations must still be verified; some manufacturers choose to add a “CSA only” marking after additional testing.
A: Yes, if the manufacturer obtains a CB Test Certificate (IECEE) covering the IEC 60601-2-47 requirements and then applies for national certification through a NCB (e.g., CSA Group). However, Canadian deviations must still be verified; some manufacturers choose to add a “CSA only” marking after additional testing.
Q: What are the common reasons for failure during certification testing?
A: The most frequent pitfalls are:
– Insufficient defibrillation protection leading to excess leakage after pulse.
– Noise levels exceeding 30 µV due to poor PCB layout or inadequate filtering.
– Inaccurate heart rate measurement at low amplitudes.
– Incomplete clinical validation reports for arrhythmia detection algorithms.
A: The most frequent pitfalls are:
– Insufficient defibrillation protection leading to excess leakage after pulse.
– Noise levels exceeding 30 µV due to poor PCB layout or inadequate filtering.
– Inaccurate heart rate measurement at low amplitudes.
– Incomplete clinical validation reports for arrhythmia detection algorithms.
Q: Is software-only analysis covered by the standard?
A: Yes, if the software is part of the whole system sold for ambulatory ECG analysis (e.g., a cloud-based report service). The standard applies to the entire intended end‑to‑end functionality, including data integrity, time synchronization, and analysis accuracy. Manufacturers of standalone software that receives raw ECG data from a recorder may need to conform to specific clauses on analysis performance.
A: Yes, if the software is part of the whole system sold for ambulatory ECG analysis (e.g., a cloud-based report service). The standard applies to the entire intended end‑to‑end functionality, including data integrity, time synchronization, and analysis accuracy. Manufacturers of standalone software that receives raw ECG data from a recorder may need to conform to specific clauses on analysis performance.
Document reference year: 2026 — This article reflects the standard edition as of 2026. Always verify the latest version with CSA Group or your certification body.